Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial

Lucia Masarova, Keyur P. Patel, Kate J. Newberry, Jorge Cortes, Gautam Borthakur, Marina Konopleva, Zeev Estrov, Hagop Kantarjian, Srdan Verstovsek

Research output: Contribution to journalArticle

50 Scopus citations

Fingerprint Dive into the research topics of 'Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences